Clinical Trial Update: Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of bevacizumab with carboplatin and paclitaxel in ovarian, fallopian tube, or primary peritoneal cancer; the study was terminated with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: UConn Health | Conditions: Ovarian Cancer, Peritoneal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2010-11-16